Altium Capital Management LP Syros Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $1.18 Million - $4.41 Million	-1,160,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $366,463 - $523,839	-112,412 Reduced 8.83%	1,160,000 $3.78 Million
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $797,517 - $1.11 Million	195,470 Added 18.15%	1,272,412 $5.56 Million
Q2 2021 Aug 13, 2021	BUY	$5.01 - $7.48 $4.76 Million - $7.11 Million	950,240 Added 749.98%	1,076,942 $5.87 Million
Q1 2021 May 06, 2021	BUY	$7.19 - $14.95 $910,987 - $1.89 Million	126,702 New	126,702 $948,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.